Platinum antitumour agents: a review of (bio)analysis
- PMID: 1630874
- DOI: 10.1007/BF01962689
Platinum antitumour agents: a review of (bio)analysis
Abstract
This paper summarizes analytical techniques in order to get a clear picture of the ins and outs of the (bio)analysis of platinum-containing compounds. The antitumour agent cisplatin has become an indispensable drug for the cure of a variety of cancer diseases. Since its introduction in the early seventies, about 2,000 related platinum complexes were designed to devoid the dose-limiting nephrotoxicity. Some of them were introduced for clinical trial, such as carboplatin and iproplatin. To investigate the mechanism of action and pharmaco-kinetic behaviour, several interesting assays for total and specific platinum determination in biological matrices have been developed, each with its own possibilities and limitations.
Similar articles
-
Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological media.J Pharm Biomed Anal. 1990;8(1):1-30. doi: 10.1016/0731-7085(90)80003-8. J Pharm Biomed Anal. 1990. PMID: 2102260 Review.
-
High-performance liquid chromatographic determination of cisplatin as platinum(II) in a pharmaceutical preparation and blood samples of cancer patients.J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):175-9. doi: 10.1016/s0378-4347(97)00038-8. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9200532
-
Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.Bull Cancer. 1987;74(4):433-6. Bull Cancer. 1987. PMID: 3311237 Clinical Trial.
-
Determination of platinum (II,IV) and palladium(II) as thiocyanate complexes by capillary zone electrophoresis analysis of carboplatin and similar drugs.J Chromatogr A. 1999 Feb 26;834(1-2):321-7. doi: 10.1016/s0021-9673(98)00848-6. J Chromatogr A. 1999. PMID: 10189692
-
Clinical pharmacokinetics and dose optimisation of carboplatin.Clin Pharmacokinet. 1997 Sep;33(3):161-83. doi: 10.2165/00003088-199733030-00002. Clin Pharmacokinet. 1997. PMID: 9314610 Review.
Cited by
-
Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats.Indian J Pharmacol. 2016 Mar-Apr;48(2):168-71. doi: 10.4103/0253-7613.178834. Indian J Pharmacol. 2016. PMID: 27127319 Free PMC article.